首页> 外文期刊>Clinical and applied thrombosis/hemostasis >Incidence of antiheparin-platelet factor 4 antibodies and heparin-induced thrombocytopenia in Turkish patients undergoing cardiac surgery.
【24h】

Incidence of antiheparin-platelet factor 4 antibodies and heparin-induced thrombocytopenia in Turkish patients undergoing cardiac surgery.

机译:接受心脏手术的土耳其患者中抗肝素-血小板因子4抗体的发生率和肝素诱导的血小板减少症。

获取原文
获取原文并翻译 | 示例
           

摘要

The frequency of antiheparin-platelet factor 4 antibodies by means of antigenic and functional assays ((14) C-serotonin release assay and citrated plasma platelet aggregation) was determined in 115 Turkish patients undergoing cardiac surgery. Blood samples were taken immediately before surgery and on days 5 and 10 +/- 2. Platelet counts were recorded and thrombotic events were determined by clinical methods. Antibody generation measured by enzyme-linked immunosorbent assay before surgery (n = 44) and on days 5 (n = 44) and 10 (n = 115) was 15.9%, 34.1%, and 65.2%, respectively. Positive samples from functional assays were 4.4% on day 0 and 7.0% on day 10. All positive samples had been negative on day 0. A high frequency of antiheparin-platelet factor 4 antibody generation and a low frequency of clinical heparin-induced thrombocytopenia were determined in these patients. These results obtained for Turkish patients are similar to those of other studies of heparin-induced thrombocytopenia.
机译:在115例接受心脏手术的土耳其患者中,通过抗原和功能测定法((14)C-血清素释放测定法和柠檬酸血浆血小板聚集)确定了抗肝素-血小板因子4抗体的频率。在手术前即第5天和第10 +/- 2天采血。记录血小板计数,并通过临床方法确定血栓形成事件。在手术前(n = 44)和第5天(n = 44)和第10天(n = 115)通过酶联免疫吸附测定法测量的抗体生成分别为15.9%,34.1%和65.2%。功能分析的阳性样本在第0天为4.4%,在第10天为7.0%。所有阳性样本在第0天均为阴性。抗肝素-血小板因子4抗体的产生频率较高,而临床肝素诱导的血小板减少症的发生频率较低在这些患者中确定。土耳其患者获得的这些结果与肝素诱导的血小板减少症的其他研究相似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号